Skip to content
Subscribe
Newsletter
Advertise
MDA.org
Donate
Subscribe
Donate
Menu
Magazine
Current Issue
Past Issues
Featured Content
Topics
Advocacy
Finding a Diagnosis
Get Involved
Health
Inclusion
Independence
Lifestyle
News
Personal Stories
Science + Research
Diseases A-Z
Blog
Podcast
Product Guide
Career Quest
Research Advances
Blog Post
FDA Approves AveXis’ Zolgensma for Treatment of Spinal Muscular Atrophy in Pediatric Patients
By
Jeanene Swanson
|
May 24, 2019
Blog Post
Do You Know ALS? Read About the Latest Research.
By
Jeanene Swanson
|
May 15, 2019
Blog Post
Biogen Releases Letter to ALS Community
By
MDA Staff
|
May 2, 2019
Blog Post
FDA Grants Breakthrough Therapy Designation to Amicus’ Experimental Therapy, AT-GAA, for Late-Onset Pompe Disease
By
Jeanene Swanson
|
March 7, 2019
Blog Post
FDA Accepts Sarepta Therapeutics’ New Drug Application (NDA) for Golodirsen to Treat DMD Amenable to Exon 53 Skipping
By
Jeanene Swanson
|
March 1, 2019
Blog Post
MDA Awards Venture Philanthropy Grant to AcuraStem to Develop Treatment for ALS
By
Jeanene Swanson
|
January 15, 2019
Blog Post
FDA Grants Orphan Drug Designation to Myonexus Therapeutics’ MYO-102 Gene Therapy Drug for Limb-Girdle Muscular Dystrophy Type 2D
By
Jeanene Swanson
|
January 4, 2019
Blog Post
C9ORF72 Mutation Most Common Cause of Familial ALS, FTD, ALS-FTD
By
Amy Madsen
|
September 20, 2011
Blog Post
National ALS Registry Now Open
By
Miriam Davidson
|
October 19, 2010
« Previous
1
…
8
9
10
Skip to content
Open toolbar
Accessibility Tools
Accessibility Tools
Increase Text
Increase Text
Decrease Text
Decrease Text
Grayscale
Grayscale
High Contrast
High Contrast
Negative Contrast
Negative Contrast
Light Background
Light Background
Links Underline
Links Underline
Readable Font
Readable Font
Reset
Reset